Skip to content

Trial Summary

The DYNAMIC-Pancreas study aims to see whether a test called “circulating tumour DNA” can be used to decide the type and duration of post-surgery chemotherapy.



ACTRN/NCT /ethics:


Scientific title:

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Early Stage Pancreatic Cancer: A Multicentre Randomised Study (DYNAMIC- Pancreas)

Sponsor / Cooperative group:

Marcus Foundation

Trial & Patient Characteristics

Cancer TypePancreas
Trial TypeTreatment
PhasePhase II, Phase III
Age Range18 years and older
Tumour Stream -
Cancer StageEarly\In Situ
Anticipated Start Date2018-03-26
Anticipated End Date-

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorHannah Adelson
Phone08 8206 4835
Principal InvestigatorDr Amitesh Roy
Recruitment StatusRecruiting